Sep 29

PQA 06 - PQA 06: Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement

3248 - Survival Outcomes and Toxicity with Reduced-Dose ARPI Therapy: Rationale for the ENHANCE Phase III Trial

02:15pm - 03:30pm ET

Presenter(s)

Ananya Choudhury, PhD, MA MRCP FRCR - The Christie NHS Foundation Trust and University of Manchester, Manchester, Greater Manchest